The table below shows RESMED INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Operating cash flow
$1.81B
$1.75B
$1.40B
$693.30M
$351.15M
$736.72M
Capital expenditure
$156.28M
$89.86M
$99.46M
$119.67M
$134.84M
$102.71M
Investing cash flow
-$545.20M
-$200.04M
-$269.78M
-$1.16B
-$229.92M
-$158.46M
Dividends paid
$349.66M
$310.88M
$282.32M
$258.28M
RMD operating cash flow (10-K history)
RESMED INC reported operating cash flow of $1.81B for fiscal year 2026. That is up 3.1% from $1.75B in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $414.05M (FY 2017) to $1.81B. Figures come from the company's audited annual reports as filed with the SEC.
